be_ixf;ym_202412 d_22; ct_50

Latest Insights on ATEN

Guide to Analyzing Insider Sentiment: Tiffany & Co. Example November 15, 2017 by Optin Adventure Capitalist Last week, we booked a quick +52.4% profit on AeroVironment (AVAV). I say “quick” because AVAV was in our Adventure Capitalist portfolio for less than seven months. AeroVironment designs, develops, produces, supports and operates unmanned aircraft systems (UAS) and efficient energy systems (EES) in the U.S. and internationally. Through intensive research, I found that this company was the […]
federal reserve The Federal Reserve’s Threat to the Market November 14, 2017 by Jocelynn Smith U.S. Economy The Federal Reserve has one major policy meeting left in 2017 and its decision regarding rates could be the catalyst that derails the market's rally.
If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases. Gene Editing: The Cure for Every Disease? November 2, 2017 by Ian Dyer Investment Opportunities If tests on animals continue to be successful, gene editing could be the long-awaited cure for cancer, AIDS and many other diseases.
No Year-end ‘Window Dressing’ Needed – Our Core Strategy Gains of 2017 October 25, 2017 by Optin Wall Street Front Runner Since last month’s update (9/27/17), we closed eight more trades in Wall Street Front Runner. Six “core” trades from the S&P 600: Axcelis Technologies Inc. (NASD: ACLS) … +4.8% NMI Holdings Inc. (NASD: NMIH) … +1.5% Pacific Premier Bancorp Inc. (NASD: PPBI) …     +0.0% Photronics Inc. (NASD: PLAB) … -3.7% Par Pacific Holdings Inc. (NYSE: PARR) … -5.3% […]
It’s past time to diversify and inject a bit of new blood into your portfolio. Trading IPO stocks can be a risky bet, but it can also be quite rewarding. These 3 IPOs Are a Breath of Fresh Air for Investors October 11, 2017 by Joseph Hargett Investment Opportunities It’s past time to diversify and inject a bit of new blood into your portfolio. Trading IPO stocks can be a risky bet, but it can also be quite rewarding.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

Share This